Sudarshan Pharma Industries Ltd

With a decisive intraday surge to Rs 41.4 on 13 Jul 2026, Sudarshan Pharma Industries Ltd has reached a fresh 52-week high, marking a 39.11% gain over the past year and significantly outperforming the Sensex’s 5.87% decline during the same period.

Sudarshan Pharma Industries Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality assessments. The micro-cap specialty chemicals company has demonstrated robust operational growth, market-beating returns, and a bullish technical outlook, prompting this positive revision in its investment rating.

Sudarshan Pharma Industries Ltd has demonstrated a notable shift in price momentum, supported by a range of technical indicators signalling a bullish trend. The stock’s recent performance, combined with upgraded technical grades and a strong Mojo Score, suggests growing investor confidence in this micro-cap specialty chemicals company.

With a decisive break above Rs 40.9 on 7 Jul 2026, Sudarshan Pharma Industries Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This surge comes amid a backdrop of strong technical signals that have aligned to propel the stock well beyond its previous resistance levels.

Sudarshan Pharma Industries Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish trend. Despite a modest day change of 0.10% to close at ₹39.53, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages. This article analyses these developments in detail, placing them in the context of the company’s recent performance and broader market trends.

Sudarshan Pharma Industries Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, signalling potential upside momentum for this specialty chemicals micro-cap stock.

Sudarshan Pharma Industries Ltd has seen its investment rating downgraded from Buy to Hold as of 1 July 2026, reflecting a nuanced reassessment across quality, valuation, financial trends, and technical indicators. Despite strong long-term returns and robust quarterly financials, evolving technical signals and debt concerns have tempered enthusiasm among analysts.

Sudarshan Pharma Industries Ltd, a micro-cap player in the Specialty Chemicals sector, has experienced a nuanced shift in its technical momentum, prompting a downgrade in its Mojo Grade from Buy to Hold as of 1 July 2026. Despite a 2.35% rise in the stock price on 2 July 2026, the technical indicators present a complex picture, reflecting both bullish and bearish signals across different timeframes.

With a decisive surge to Rs 40 on 24 Jun 2026, Sudarshan Pharma Industries Ltd has reached a fresh 52-week high, marking a 43.57% gain over the past year and outpacing the Sensex’s decline of 6.11% during the same period. This milestone reflects a strong alignment of technical indicators and sustained price momentum that has propelled the stock well above its key moving averages.

With a decisive surge to Rs 38.99 on 23 Jun 2026, Sudarshan Pharma Industries Ltd has reached a fresh 52-week high, marking a 38.02% gain over the past year and outpacing the Sensex's decline of 5.83% during the same period. This milestone reflects a robust alignment of technical indicators and sustained price momentum that has propelled the stock well above its key moving averages.

Sudarshan Pharma Industries Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 June 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 23 June 2026, providing investors with the most up-to-date analysis.

With a decisive intraday surge to Rs 38.54 on 22 Jun 2026, Sudarshan Pharma Industries Ltd has reached a fresh 52-week high, extending its impressive 28.47% return over the past year. This milestone comes amid a backdrop of strong technical momentum and a market environment that has broadly supported mid and small cap stocks.

With a decisive break above Rs 38 on 16 Jun 2026, Sudarshan Pharma Industries Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This surge comes after a sustained four-day rally that has propelled the stock 7.54% higher, outperforming its specialty chemicals sector peers by 1.19% today.

With a decisive surge to Rs 36.95 on 15 Jun 2026, Sudarshan Pharma Industries Ltd has reached a fresh 52-week high, marking a 24.7% gain over the past year and outpacing the Sensex’s decline of 5.9% during the same period. This milestone reflects a strong alignment of technical indicators and sustained price momentum that has propelled the stock well above its key moving averages.

Sudarshan Pharma Industries Ltd is rated Buy by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 June 2026, providing investors with the latest insights into its performance and outlook.

Sudarshan Pharma Industries Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underpinned by a confluence of technical indicators including MACD, moving averages, and Bollinger Bands, signalling renewed investor interest and potential upside in the specialty chemicals sector.

Sudarshan Pharma Industries Ltd has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance as of early June 2026. Despite a slight dip in the share price, the stock continues to demonstrate resilience with mixed signals from key technical indicators such as MACD, RSI, and moving averages, warranting a nuanced analysis for investors navigating the specialty chemicals sector.

Sudarshan Pharma Industries Ltd is rated Buy by MarketsMOJO, with this rating last updated on 20 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 01 June 2026, providing investors with the most up-to-date insight into the stock’s performance and outlook.